Jacob Chacko
CIK 1608936 · PRESIDENT AND CEO · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.81M
Companies
4
Total Filings
53
Lifetime Open-Market Net
-$3.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORIC | PRESIDENT AND CEO | 581,711 | $8.27 | $4.81M | -$3.49M | 33 | 2026-01-06 |
| FDMT | Director | 0 | $8.83 | $0 | -$100.3K | 6 | 2025-06-20 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | Director | — | $76.01 | — | $0 | 2 | 2020-06-17 |
| Ignyta, Inc. (RXDX) Delisted | Chief Financial Officer | 70,572 | $199.92 | $14.11M | $117.1K | 11 | 2018-01-05 |
Recent Filings · Page 6 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-09 | Ignyta, Inc. (RXDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-11-24 | Ignyta, Inc. (RXDX) Delisted | Buy (P) | +1,598 | $10.3K | EDGAR |
| 2014-08-19 | Ignyta, Inc. (RXDX) Delisted | Buy (P) | +1,840 | $13.8K | EDGAR |
Showing 51–53 of 53
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.